EPS222
Cardiovascular Diseases
PreclinicalActive
Key Facts
About Eusol Biotech
Taiwanese biotech advancing rhFGF1‑based therapies for nerve regeneration and niche generics.
View full company profileTherapeutic Areas
Other Cardiovascular Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Anti-platelet | Dawah Pharmaceuticals | Development |
| Autonomic Therapy Initiative (ATI) | BIOS Health | Pre-clinical |
| Cardiology Diagnostics Program | Aptus Biosciences | Discovery |
| Cardiovascular Collaboration | Unnatural Products | Discovery |
| SBX 2000 | Stramsen Biotech | Early-stage Clinical |
| Not specified on provided pages | Cadila Pharmaceuticals | Commercial (World's First Claim) |
| Cardiovascular Biomarkers R&D | Firalis | Development |